Bansiwal Reeta, Mahey Reeta, Malhotra Neena, Singh Neeta, Saini Monika, Bhatt Ashok, Nilima Nilima, Mani Kalaivani, Cheluvaraju Rohitha, Rajput Monika, Bhatla Neerja
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
J Reprod Infertil. 2023 Apr-Jun;24(2):117-131. doi: 10.18502/jri.v24i2.12497.
The purpose of the current study was to evaluate patient-oriented strategies encompassing individualized oocyte number (POSEIDON) criteria, validate stratification of low prognosis women, and prognosticate their reproductive potential in terms of cumulative live birth rate (CLBR) in Indian women.
Out of 4048 women who underwent IVF/ICSI, 3287 women met the criteria for final evaluation of CLBR. They criteria were divided into (a) group 1a as cases with <4 oocytes retrieved and 1b with 4-9 oocytes retrieved; (b) group 2a as cases with <4 oocytes retrieved and 2b with 4-9 oocytes retrieved; (c) group 3 (<35 years, AMH <1.2 , AFC <5); and (d) group 4 (≥35 years, AMH <1.2 , AFC <5). Non-POSEIDON group was sub-divided into normo-responders (10-20 oocytes) and hyper-responder (>20 oocytes).
Overall CLBR was two-fold lower in POSEIDON group as compared to non-POSEIDON group (p<0.001). For every one-year increase in the age, the odds of CLBR decreased by 4% (OR 0.96, CI 0.93-0.99) in POSEIDON group and by 5% (OR 0.95, CI 0.92-0.98) in non-POSEIDON group. For every unit increase in number of oocytes retrieved, the odds of CLBR increased by 1.22 times (OR1.22, CI 1.16-1.28) in POSEIDON group and by 1.08 times (OR 1.08, CI 1.05-1.11) in non-POSEIDON group. Among POSEIDON groups, the highest values in CLBR belonged to group 1b followed by 3, 2b, 4, 1a, and 2a.
POSEIDON stratification of low-prognosis women undergoing IVF may be considered valid to prognosticate and counsel women undergoing IVF. Prospective studies will strengthen its validity among different ethnic populations.
本研究旨在评估包含个体化卵母细胞数量(POSEIDON)标准的以患者为导向的策略,验证低预后女性的分层情况,并根据印度女性的累积活产率(CLBR)预测其生殖潜力。
在4048例行体外受精/卵胞浆内单精子注射的女性中,3287名女性符合CLBR最终评估标准。这些标准被分为:(a)第1a组为获卵数<4枚的病例,第1b组为获卵数4 - 9枚的病例;(b)第2a组为获卵数<4枚的病例,第2b组为获卵数4 - 9枚的病例;(c)第3组(年龄<35岁,抗缪勒氏管激素<1.2,窦卵泡计数<5);以及(d)第4组(年龄≥35岁,抗缪勒氏管激素<1.2,窦卵泡计数<5)。非POSEIDON组又细分为正常反应者(获卵数10 - 20枚)和高反应者(获卵数>20枚)。
与非POSEIDON组相比,POSEIDON组的总体CLBR低两倍(p<0.001)。在POSEIDON组中,年龄每增加一岁,CLBR的几率降低4%(比值比0.96,可信区间0.93 - 0.99),在非POSEIDON组中降低5%(比值比0.95,可信区间0.92 - 0.98)。在POSEIDON组中,每增加一个获卵数单位,CLBR的几率增加1.22倍(比值比1.22,可信区间1.16 - 1.28),在非POSEIDON组中增加1.08倍(比值比1.08,可信区间1.05 - 1.11)。在POSEIDON组中,CLBR最高值属于第1b组,其次是第3组、第2b组、第4组、第1a组和第2a组。
对于接受体外受精的低预后女性,POSEIDON分层可被认为对预测和咨询接受体外受精的女性是有效的。前瞻性研究将加强其在不同种族人群中的有效性。